Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Global health
Authors
About
Help
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Global health
Authors
About
Help
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 15, Issue 6
Severe myopericarditis following the third dose of an mRNA COVID-19 vaccine: utility of a multimodal treatment approach
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Case Reports: Novel treatment (new drug/interventions; established drug/procedure in new situation)
Severe myopericarditis following the third dose of an mRNA COVID-19 vaccine: utility of a multimodal treatment approach
Online download statistics by month:
Online download statistics by month: June 2022 to February 2023
Abstract
Full
Pdf
Jun 2022
123
124
22
Jul 2022
534
539
103
Aug 2022
261
268
37
Sep 2022
103
101
20
Oct 2022
153
13
3
Nov 2022
232
6
7
Dec 2022
180
4
4
Jan 2023
83
2
0
Feb 2023
24
1
0
Total
1693
1058
196
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF